Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single Run

Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis (ANN ARBOR, Mich. – August 3, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation sequencing on... Read more

European Patent Office to Grant MilliporeSigma’s Patent Application for CRISPR Technology

Patent application covers integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Related patent application recently awarded in Australia; similar patents pending in other countries, favorable outcomes anticipated Billerica, Massachusetts, August 3, 2017 — MilliporeSigma today announced that the European Patent Office (EPO) has issued a “Notice of Intention to Grant” for MilliporeSigma’s... Read more

Edico Genome Signs Contracts With NHGRI And NCI For Use Of DRAGEN For Cancer Research

SAN DIEGO, Aug. 2, 2017 — Edico Genome today announced it has signed contracts with the National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI) for the use of its DRAGENTM(Dynamic Read Analysis for Genomics) Bio-IT platform. Continuing their initiatives to advance cancer research, NHGRI and NCI purchased Edico Genome’s DRAGEN Somatic pipeline and DRAGEN Genome pipeline, ensuring accuracy, reducing costs... Read more

Thermo Fisher Scientific Completes CE-IVD Registration of its QuantStudio™ 5 Dx System for In Vitro Diagnostic Use in Europe

SAN DIEGO, July 31, 2017 /PRNewswire/ — AACC — Thermo Fisher Scientific today announced the successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR System for sale in European countries. The platform provides European customers with modern and user-friendly instrument that is designed to easily integrate into their existing diagnostic workflow. The product will be on exhibit... Read more

Thermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017

Jul. 31, 2017 SAN DIEGO, July 31, 2017 /PRNewswire/ — AACC — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, is showcasing its latest advancements in clinical and research-based solutions during the 2017 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo, being held July 31 – August 3 at the San Diego Convention Center. Among the products displayed within booth #4039 is a... Read more

New England Biolabs® and TTP plc collaborate to provide services for molecular diagnostics

New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products CAMBRIDGE, England and IPSWICH, Mass., July 28, 2017 /PRNewswire/ — TTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, today announce... Read more

Unique concept of MDx, Seegene Random Access System, announced at AACC 2017

Seoul, South Korea – July 26, 2017 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the “System”) at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July 30 to August 3. The ‘Seegene Random Access... Read more

Agilent Technologies Introduces Real-Time PCR System for Clinical Diagnostics in Europe

AriaDx Provides Modular Solution for Diagnostic Labs and Assay Developers SANTA CLARA, Calif., July 25, 2017 Agilent Technologies Inc. (NYSE: A) today expanded its portfolio of instruments for molecular diagnostics with the introduction of the AriaDx Real-Time PCR System. AriaDx is the only modular real-time PCR instrument on the market intended for in vitro diagnostic... Read more